ITHACA — Rheonix, Inc., an Ithaca–based microfluidics company, today announced the addition of Frank Gill as vice president of manufacturing.
Gill will be responsible for formulating and executing the company’s operations strategy as it scales from prototype volumes to fully-automated production of life science and in-vitro diagnostics products, the company said in a news release.
Gill will oversee manufacturing of Rheonix-instrument platforms, reagent kits, and the Rheonix CARD system, an automated-microfluidic platform capable of analyzing raw samples in a variety of applications, the company said.
(Sponsored)
In the Market to Build? Get Started in 4 Simple Steps
Finding the perfect home isn’t always easy, especially in our world today. The U.S. Housing Shortage has created an ongoing challenge for homebuyers across the nation, opening the door to
Keeping Your Firm Secure on the Road to Digitization
By Dan Hernborg Sales Engineer With the looming threat of a potential recession and economic downturn, many professional service firms are looking to reduce costs and increase efficiency in preparation.
Most recently, Gill served as director of reagent-manufacturing operations at 454 Life Sciences, a division of the Switzerland–based Roche Group.
Contact Reinhardt at ereinhardt@cnybj.com
